XAV939 is a small molecule inhibitor of the Wnt-signaling pathway that blocks Wnt-signaling in cancer cell lines, resulting in a dramatic stabilization of the axin protein and inhibiting the β-catenin-regulated transcription (42). This evidence concerns the gene AXIN1 and cancer.